Allergicasone
Product Description
Alesraa Pharmaceutical Optime
-
EG -
2024On CPHI since
-
2Certificates
-
500 - 999Employees
Company types
Primary activities
Categories
Specifications
Alesraa Pharmaceutical Optime
-
EG
-
2024On CPHI since
-
2Certificates
-
500 - 999Employees
Company types
Primary activities
More Products from Alesraa Pharmaceutical Optime (3)
-
Product Dapablix/Dapablix Met
Dapablix contains dapagliflozin, an SGLT2 inhibitor that effectively reduces blood glucose levels by promoting renal glucose excretion. It is indicated for the management of type 2 diabetes mellitus, offering additional benefits such as weight reduction and cardiovascular risk mitigation.
Dapablix Met c... -
Product Larosuzet
Larosuzet integrates the strengths of ezetimibe, an intestinal cholesterol absorption inhibitor, and rosuvastatin, an HMG-CoA reductase inhibitor, to achieve optimal lipid control. This dual-action formula reduces LDL-C and total cholesterol levels more effectively than either agent alone. Larosuzet is sui... -
Product Vonacidan
Vonacidan (Vonoprazan 10 mg and 20 mg film-coated tablets) a potent potassium-competitive acid blocker (P-CAB) that offers rapid and sustained suppression of gastric acid secretion. Unlike traditional proton pump inhibitors (PPIs), Vonacidan provides faster onset and more stable pH control, making it ...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance